Addex Therapeutics Advances Promising New Treatment for Severe Chronic Cough

Geneva, Wednesday, 29 April 2026.
On April 29, 2026, Addex Therapeutics announced a novel drug candidate that not only suppresses severe chronic cough but remarkably improves underlying lung health in preclinical respiratory disease models.